Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses

Aditya Bagrodia, Brian Harrow, Zhuo Wei Liu, Ephrem O. Olweny, Stephen Faddegon, Gang Yin, Yung Khan Tan, Woong Kyu Han, Yair Lotan, Vitaly Margulis, Jeffrey A Cadeddu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: To evaluate a nomogram using the RENAL Nephrometry Score (RENAL-NS) that was developed to characterize masses as benign vs. malignant and high vs. low grade in our patients with small renal masses treated with partial nephrectomy (PN). The nomogram was previously developed and validated in patients with widely variable tumor sizes. Materials and methods: Retrospective review of PN performed between 1/2003 and 7/2011. Imaging was reviewed by a urologic surgeon for RENAL-NS. Final pathology was used to classify tumors as benign or malignant and low (I/II) or high (III/IV) Fuhrman grade. Patient age, gender, and RENAL score were entered into the nomogram described by Kutikov et al. to determine probabilities of cancer and high-grade disease. Area under the curve was determined to assess agreement between observed and expected outcomes for prediction of benign vs. malignant disease and for prediction of high- vs. low-grade or benign disease. Results: A total of 250 patients with 252 masses underwent PN during the study period; 179/250 (71.6%) had preoperative imaging available. RENAL-NS was assigned to 181 masses. Twenty-two percent of tumors were benign. Eighteen percent of tumors were high grade. Area under the curve was 0.648 for predicting benign vs. malignant disease and 0.955 for predicting low-grade or benign vs. high-grade disease. Conclusions: The RENAL-NS score nomogram by Kutikov does not discriminate well between benign and malignant disease for small renal masses. The nomogram may potentially be useful in identifying high-grade tumors. Further validation is required where the nomogram probability and final pathologic specimen are available.

Original languageEnglish (US)
JournalUrologic Oncology: Seminars and Original Investigations
Volume32
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Nomograms
Kidney
Nephrectomy
Neoplasms
Area Under Curve
Pathology

Keywords

  • Kidney cancer
  • Nephrometry
  • Nomogram
  • Prediction
  • Prognostics
  • RENAL
  • Renal cell cancer
  • Validation

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses. / Bagrodia, Aditya; Harrow, Brian; Liu, Zhuo Wei; Olweny, Ephrem O.; Faddegon, Stephen; Yin, Gang; Tan, Yung Khan; Han, Woong Kyu; Lotan, Yair; Margulis, Vitaly; Cadeddu, Jeffrey A.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 32, No. 1, 01.2014.

Research output: Contribution to journalArticle

@article{3ebec2f3af7d478882d132448ab0297d,
title = "Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses",
abstract = "Objective: To evaluate a nomogram using the RENAL Nephrometry Score (RENAL-NS) that was developed to characterize masses as benign vs. malignant and high vs. low grade in our patients with small renal masses treated with partial nephrectomy (PN). The nomogram was previously developed and validated in patients with widely variable tumor sizes. Materials and methods: Retrospective review of PN performed between 1/2003 and 7/2011. Imaging was reviewed by a urologic surgeon for RENAL-NS. Final pathology was used to classify tumors as benign or malignant and low (I/II) or high (III/IV) Fuhrman grade. Patient age, gender, and RENAL score were entered into the nomogram described by Kutikov et al. to determine probabilities of cancer and high-grade disease. Area under the curve was determined to assess agreement between observed and expected outcomes for prediction of benign vs. malignant disease and for prediction of high- vs. low-grade or benign disease. Results: A total of 250 patients with 252 masses underwent PN during the study period; 179/250 (71.6{\%}) had preoperative imaging available. RENAL-NS was assigned to 181 masses. Twenty-two percent of tumors were benign. Eighteen percent of tumors were high grade. Area under the curve was 0.648 for predicting benign vs. malignant disease and 0.955 for predicting low-grade or benign vs. high-grade disease. Conclusions: The RENAL-NS score nomogram by Kutikov does not discriminate well between benign and malignant disease for small renal masses. The nomogram may potentially be useful in identifying high-grade tumors. Further validation is required where the nomogram probability and final pathologic specimen are available.",
keywords = "Kidney cancer, Nephrometry, Nomogram, Prediction, Prognostics, RENAL, Renal cell cancer, Validation",
author = "Aditya Bagrodia and Brian Harrow and Liu, {Zhuo Wei} and Olweny, {Ephrem O.} and Stephen Faddegon and Gang Yin and Tan, {Yung Khan} and Han, {Woong Kyu} and Yair Lotan and Vitaly Margulis and Cadeddu, {Jeffrey A}",
year = "2014",
month = "1",
doi = "10.1016/j.urolonc.2013.03.003",
language = "English (US)",
volume = "32",
journal = "Urologic Oncology: Seminars and Original Investigations",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses

AU - Bagrodia, Aditya

AU - Harrow, Brian

AU - Liu, Zhuo Wei

AU - Olweny, Ephrem O.

AU - Faddegon, Stephen

AU - Yin, Gang

AU - Tan, Yung Khan

AU - Han, Woong Kyu

AU - Lotan, Yair

AU - Margulis, Vitaly

AU - Cadeddu, Jeffrey A

PY - 2014/1

Y1 - 2014/1

N2 - Objective: To evaluate a nomogram using the RENAL Nephrometry Score (RENAL-NS) that was developed to characterize masses as benign vs. malignant and high vs. low grade in our patients with small renal masses treated with partial nephrectomy (PN). The nomogram was previously developed and validated in patients with widely variable tumor sizes. Materials and methods: Retrospective review of PN performed between 1/2003 and 7/2011. Imaging was reviewed by a urologic surgeon for RENAL-NS. Final pathology was used to classify tumors as benign or malignant and low (I/II) or high (III/IV) Fuhrman grade. Patient age, gender, and RENAL score were entered into the nomogram described by Kutikov et al. to determine probabilities of cancer and high-grade disease. Area under the curve was determined to assess agreement between observed and expected outcomes for prediction of benign vs. malignant disease and for prediction of high- vs. low-grade or benign disease. Results: A total of 250 patients with 252 masses underwent PN during the study period; 179/250 (71.6%) had preoperative imaging available. RENAL-NS was assigned to 181 masses. Twenty-two percent of tumors were benign. Eighteen percent of tumors were high grade. Area under the curve was 0.648 for predicting benign vs. malignant disease and 0.955 for predicting low-grade or benign vs. high-grade disease. Conclusions: The RENAL-NS score nomogram by Kutikov does not discriminate well between benign and malignant disease for small renal masses. The nomogram may potentially be useful in identifying high-grade tumors. Further validation is required where the nomogram probability and final pathologic specimen are available.

AB - Objective: To evaluate a nomogram using the RENAL Nephrometry Score (RENAL-NS) that was developed to characterize masses as benign vs. malignant and high vs. low grade in our patients with small renal masses treated with partial nephrectomy (PN). The nomogram was previously developed and validated in patients with widely variable tumor sizes. Materials and methods: Retrospective review of PN performed between 1/2003 and 7/2011. Imaging was reviewed by a urologic surgeon for RENAL-NS. Final pathology was used to classify tumors as benign or malignant and low (I/II) or high (III/IV) Fuhrman grade. Patient age, gender, and RENAL score were entered into the nomogram described by Kutikov et al. to determine probabilities of cancer and high-grade disease. Area under the curve was determined to assess agreement between observed and expected outcomes for prediction of benign vs. malignant disease and for prediction of high- vs. low-grade or benign disease. Results: A total of 250 patients with 252 masses underwent PN during the study period; 179/250 (71.6%) had preoperative imaging available. RENAL-NS was assigned to 181 masses. Twenty-two percent of tumors were benign. Eighteen percent of tumors were high grade. Area under the curve was 0.648 for predicting benign vs. malignant disease and 0.955 for predicting low-grade or benign vs. high-grade disease. Conclusions: The RENAL-NS score nomogram by Kutikov does not discriminate well between benign and malignant disease for small renal masses. The nomogram may potentially be useful in identifying high-grade tumors. Further validation is required where the nomogram probability and final pathologic specimen are available.

KW - Kidney cancer

KW - Nephrometry

KW - Nomogram

KW - Prediction

KW - Prognostics

KW - RENAL

KW - Renal cell cancer

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=84890802462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890802462&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2013.03.003

DO - 10.1016/j.urolonc.2013.03.003

M3 - Article

C2 - 23628308

AN - SCOPUS:84890802462

VL - 32

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

SN - 1078-1439

IS - 1

ER -